FDA Drug Recalls

Recalls / Class II

Class IID-0076-2020

Product

Moxifloxacin 0.1% in BSS, Ophthalmic Injection, 0.3 mg/0.3 mL, 0.3 mL Fill in a 1 mL Single Dose Syringe, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678320

Affected lot / code info
All lots remaining within expiry.

Why it was recalled

Lack of Assurance of Sterility

Recalling firm

Firm
KRS Global Biotechnology, Inc
Notification channel
Press Release
Type
Voluntary: Firm initiated
Address
791 Park of Commerce Blvd Ste 600, N/A, Boca Raton, Florida 33487-3633

Distribution

Quantity
9920 syringes
Distribution pattern
Nationwide

Timeline

Recall initiated
2019-09-12
FDA classified
2019-10-01
Posted by FDA
2019-10-09
Terminated
2021-08-19
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0076-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls